Perceptive (clinical research company)
| Company type | Private |
|---|---|
| Industry | Clinical research organizations Pharmaceutical |
| Founded | 2021 |
| Headquarters | Nottingham, United Kingdom[1] |
Number of locations | 12+ facilities in 10+ countries |
Key people | CEO: David Herron |
| Services | Medical imaging, clinical trial management systems |
| Revenue |  $82 million (2022)[2][3] |
Number of employees | 1000-2000[1] |
| Parent | CapVest Partners/GLO Healthcare |
| Website | perceptive |
Perceptive, formerly CALYX AI,[4] is a corporate spin-off from Parexel International.[2][5] Perceptive is a British–American provider of biopharmaceutical services formed by the merger of CALYX AI and Invicro.[6][7][8] The company was formed in January 2021 following the strategic separation of the Parexel Informatics business from Parexel International, and provides medical imaging, e-clinical and regulatory services.[9][10]
References
[edit]- ^ a b "About Perceptive | Who Are Perceptive?". Perceptive.
- ^ a b "Merck and Veeva Ink 10-Year Partnership Agreement". BioPharm International.
- ^ "Calyx Partnership with Top 5 CRO Extended through 2024". finance.yahoo.com.
- ^ "Calyx Named Medical Imaging Provider by Clinscience". Pubs - Clinical Research News Online.
- ^ "Calyx Spins Out of Parexel". Applied Clinical Trials Online.
- ^ "Calyx and Invicro agree to combine to create a global leader in medical imaging and software solutions for the clinical research community". www.prnewswire.com.
- ^ "Calyx and Invicro Rebrand as Perceptive – Contract Pharma". October 1, 2024.
- ^ "150 Orphan Drug Indication Approvals to Perceptive IRT/RTSM". Perceptive.
- ^ "Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services". Retrieved 29 March 2023.
- ^ "Calyx rebrands as Perceptive. Introducing Perceptive: A New Name for the Global Leader in Discovery, eClinical, and Imaging Services and Solutions". Perceptive. 2024-12-16. Retrieved 2024-12-16.